| Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma Models N Salomon, A Helm, A Selmi, C Fournier, M Diken, B Schrörs, M Scholz, ... International Journal of Radiation Oncology* Biology* Physics 119 (3), 936-945, 2024 | | 2024 |
| RNA-encoded interleukin-2 with extended bioavailability amplifies RNA vaccine–induced antitumor T-cell immunity D Peters, LM Kranz, D Eisel, M Diken, S Kreiter, Ö Tureci, U Sahin, ... Cancer Immunology Research, 2024 | | 2024 |
| FRI-533 Anti-MFAP-5 siRNA loaded polycarbonate nanohydrogels for antistromal therapy in hepatocellular carcinoma P Schneider, A Fuchs, L Nuhn, B Schroers, M Diken, T Lammers, ... Journal of Hepatology 80, S435, 2024 | | 2024 |
| Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy A Bulashevska, Z Nacsa, F Lang, M Braun, M Machyna, M Diken, L Childs, ... Frontiers in Immunology 15, 1394003, 2024 | | 2024 |
| Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers JD Beck, M Diken, M Suchan, M Streuber, E Diken, L Kolb, L Allnoch, ... Cancer Cell 42 (4), 568-582. e11, 2024 | 3 | 2024 |
| The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growth L Florin, J Strunk, A Hüppner, M Sial, M Plath, S Wagner, K Freitag, ... | | 2024 |
| Rna for treatment of autoimmune diseases U Sahin, S Kreiter, C Krienke, J Petschenka, LM Kranz, M Diken US Patent App. 18/333,273, 2023 | | 2023 |
| In vivo gene silencing with novel siRNA loaded polypeptoide nanoparticles for anti-stromal therapy in hepatocellular carcinoma P Schneider, L Capelôa, H Zhang, B Schörs, Ö Öztürk, M Diken, ... Zeitschrift für Gastroenterologie 61 (08), KV199, 2023 | | 2023 |
| Experimental mouse model of hepatocellular carcinoma with and without parenchymal liver damage for rapid screening of antitumor drugs P Schneider, K Benderski, AM Sofias, F De Lorenzi, T Lammers, ... Zeitschrift für Gastroenterologie 61 (08), KV182, 2023 | | 2023 |
| Polysarcosine-functionalized mRNA lipid nanoparticles tailored for immunotherapy C Wilhelmy, IS Keil, L Uebbing, MA Schroer, D Franke, T Nawroth, M Barz, ... Pharmaceutics 15 (8), 2068, 2023 | 11 | 2023 |
| Zindywidualizowane szczepionki przeciwnowotworowe U Sahin, S Kreiter, M DIKEN, J DIEKMANN, M Koslowski, C Britten, ... | | 2023 |
| Rna formulation for immunotherapy U Sahin, H Haas, S Kreiter, M Diken, D Fritz, M Meng, LM Kranz, K Reuter US Patent App. 18/071,705, 2023 | | 2023 |
| An mRNA-encoded, long-lasting Interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers JD Beck, M Diken, M Suchan, M Streuber, E Diken, L Kolb, L Allnoch, ... bioRxiv, 2023.07. 18.549445, 2023 | | 2023 |
| Rna for treatment of autoimmune diseases U Sahin, S Kreiter, C Krienke, J Petschenka, LM Kranz, M Diken US Patent 11,701,413, 2023 | | 2023 |
| The landscape of T cell antigens for cancer immunotherapy A Peri, N Salomon, Y Wolf, S Kreiter, M Diken, Y Samuels Nature cancer 4 (7), 937-954, 2023 | 33 | 2023 |
| In vivo cancer-associated fibroblast specific gene silencing for anti-stromal therapy in primary liver cancer using novel siRNA loaded polypeptoide nanoparticles P Schneider, L Capeloa, H Zhang, M Barz, B Schoers, O Akilli-Oeztuerk, ... Journal of Hepatology 78, S28-S29, 2023 | | 2023 |
| Particles comprising a shell with RNA U Sahin, H Haas, S Kreiter, Y Hüsemann, M Diken, K Reuter, H Hefesha US Patent 11,660,338, 2023 | | 2023 |
| Individualiserede vacciner mod cancer U Sahin, M Diken, J Diekmann, M Koslowski, B Renard, C Britten, ... | | 2023 |
| Treatment involving non-immunogenic rna for antigen vaccination U Sahin, LM Kranz, M Diken, L Hilscher, S Kreiter US Patent App. 17/907,013, 2023 | | 2023 |
| Yksilöityjä rokotteita syöpää varten U Sahin, S Kreiter, M Diken, J Diekmann, M Koslowski, C Britten, J Castle, ... | | 2023 |
